Covered recipient · General Payments record
ANN M MEKILO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,087.37
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $317.71 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $85.75 | 5 |
| Novo Nordisk AS | $79.72 | 5 |
| EISAI INC. | $45.66 | 2 |
| PFIZER INC. | $34.58 | 2 |
| GlaxoSmithKline, LLC. | $30.35 | 2 |
| Acerta Pharma LLC | $14.58 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.84 | 1 |
| Actelion Pharmaceuticals US, Inc. | $13.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $13.23 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078908939 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.84 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147019246 | CMS |
| Amgen Inc. | $14.97 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115925733 | CMS |
| Amgen Inc. | $17.26 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117627870 | CMS |
| Amgen Inc. | $16.14 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115925742 | CMS |
| Amgen Inc. | $20.48 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117627872 | CMS |
| Amgen Inc. | $16.90 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115925748 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.58 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105532438 | CMS |
| Eisai Inc. | $19.95 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110793517 | CMS |
| Eisai Inc. | $25.71 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110793515 | CMS |
| GlaxoSmithKline, LLC. | $16.39 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115880148 | CMS |
| GlaxoSmithKline, LLC. | $13.96 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116353020 | CMS |
| Novo Nordisk Inc | $16.29 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268718 | CMS |
| Novo Nordisk Inc | $16.96 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100633951 | CMS |
| Novo Nordisk Inc | $14.49 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100239670 | CMS |
| Novo Nordisk Inc | $14.93 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100644585 | CMS |
| Novo Nordisk Inc | $17.05 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100418271 | CMS |
| PFIZER INC. | $15.15 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131327505 | CMS |
| PFIZER INC. | $19.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131124389 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.